|
Abstract Submission
The deadline for abstract submission
is Monday, October 31, 2005. All submissions should not exceed 450 words.
The Scientific Committee requests that authors submit their abstracts electronically
via the Conference website. To submit electronically please click on the button at
the bottom of the page and follow the step-by-step directions, which will enable you
to upload the file containing your abstract from the computer system that you are
using to access this website. To ensure your abstract retains any special characters
or formatting, the abstract must be in Microsoft Word format.
Abstract
Guidelines
Format
The body of
the uploaded abstract submission should not exceed 450 words; this
limit excludes the title, authors and affiliations.
Clearly define all concepts and abbreviations at first use. If English
is not your primary language, attempt to have your abstract reviewed
by a native English speaker. To be acceptable, abstracts shall contain
a concise statement of the research. It is recommended that the
author follow the structured format below:
Title
(not included in 450 word limit)
Use a short and concise title that indicates the content of the
abstract. Capitalize the first letter of each word except prepositions,
articles, and species names. Species names should be spelled out
at first use. Italicize scientific names of organisms (example:
Staphylococcus aureus). For therapeutic agents, only generic names
may be used (no trade names are permitted in abstract titles).
Authors/Affiliations
(not included in 450 word limit)
Authors' names should be entered using initial(s) for the first
and middle names followed by the full last name, with presenting
author underlined (e.g. AN Author1, AN Author2 and AN Author3).
All author
affiliations should be entered as follows:
1 University of London, London, UK; 2 University of Frankfurt, Frankfurt,
Germany; and 3 University of Paris, Paris, France.
Background
State the problem under investigation or a hypothesis. For therapeutic
agents, only generic names may be used (no trade names are permitted).
No figures or tables are allowed.
Methods
Explain the experimental methods used. For therapeutic agents, only
generic names may be used (no trade names are permitted). No figures
or tables are allowed.
Results
List the essential results obtained in summary form, with enough
quantitative data to permit evaluation by reviewers. For therapeutic
agents, only generic names may be used (no trade names are permitted).
No figures or tables are allowed.
Conclusion
Summarize the findings. It is unacceptable to use statements such
as "the results will be discussed". For therapeutic agents,
only generic names may be used (no trade names are permitted). No
figures or tables are allowed.
Additional
Abstract Information
In addition
to the uploaded abstract, the following additional information will
be collected on the abstract submission form:
Contact
Information
The presenting author must enter a complete address to ensure that
correspondence arrives promptly and easily.
Preferred
Form of Presentation
Poster, Oral, Either
Abstract
Category
For purposes of review and programming, abstracts are divided into
topical categories. Selection of the most appropriate category is
important as it determines who reviews your abstract. The Organizing
Committee reserves the right to reassign your abstract to a more
appropriate category.
- Advances
in HCV Replicons and Cell-based Assays
- Clinical
Development of HBV/HCV Inhibitors
- Co-Infection
with HIV and other Viruses
- Hepatocellular
Carcinoma and Fibrosis
- Immunology
& Vaccine Development
- Next
Generation of HBV Inhibitors
- Next
Generation of HCV Inhibitors
- New
Therapeutic Approaches and Emerging Targets
- Optimizing
Outcome of Therapeutics for HBV/HCV
- Pathogenesis,
Therapeutics, Viral Dynamics and Emerging Viruses
- Resistance
to Antiviral Agents
Abstract
Title (should be the same as in the uploaded abstract)
Use a short and concise title that indicates the content of the
abstract. Capitalize the first letter of each word except prepositions,
articles, and species names. Species names should be spelled out
at first use. Italicize scientific names of organisms (example:
Staphylococcus aureus). For therapeutic agents, only generic names
may be used (no trade names are permitted in abstract titles).
Sample Abstract
To view a sample abstract, click
here.
The sample form is an Adobe Acrobat document. If your computer cannot
read the sample, please click
here to download Adobe's free Acrobat Reader.
Abstract Notifications
Notifications of acceptance and
format of presentation (oral or poster presentation) will be November 14, 2005. It
is the responsibility of the corresponding/presenting author to inform all co-authors
of the disposition status. If you have not received notification by Tuesday, November
15, 2005, please call +1-770 997 2484.
If an abstract is accepted, one
author is required to register for the conference and present the paper as scheduled.
Guidelines for preparing your poster presentations will be sent if your abstract is
accepted. It is suggested that all accepted posters be set up prior to Monday, December
12, 2005.
Published
Abstract Book
Accepted abstracts will be standardized
in font and presentation. Any error that appears in the submitted abstract may appear
in the printed abstract.
Subject to availability, copies
of the Abstract Book will be available for sale after the Conference. Please contact
the Conference Secretariat.
|
